Higher expression of BHLHE40 indicating worse prognosis in glioma, regardless of pathological subtype, which emphasized the potency of BHLHE40 as prognostic biomarkers in glioma and a putative biological function in brain tumor. The gene discussed is BHLHE40; the disease is central nervous system cancer.